Systemic IL-15 promotes allogeneic cell rejection in patients treated with natural killer cell adoptive therapy.
Berrien-Elliott MM, Becker-Hapak M, Cashen AF, Jacobs M, Wong P, Foster M, McClain E, Desai S, Pence P, Cooley S, Brunstein C, Gao F, Abboud CN, Uy GL, Westervelt P, Jacoby MA, Pusic I, Stockerl-Goldstein KE, Schroeder MA, DiPersio JF, Soon-Shiong P, Miller JS, Fehniger TA.
Berrien-Elliott MM, et al. Among authors: schroeder ma.
Blood. 2022 Feb 24;139(8):1177-1183. doi: 10.1182/blood.2021011532.
Blood. 2022.
PMID: 34797911
Free PMC article.
Clinical Trial.